You will be able to link to the posters and presentations at the start of the summit on Friday, July 11.
Please reach out if you would like to meet with a member of the KalVista team at the 2025 HAEA National Summit.
medinfo@kalvista.com
Effectiveness of Sebetralstat for the On-demand Treatment of Mucosal Hereditary Angioedema Attacks: Interim Analysis from KONFIDENT-S
Impact of Injectable HAE On-demand Treatments on Health-related Quality of Life: A Patient and Caregiver Interview Study
Impact of Oral Sebetralstat on Anxiety Associated with Hereditary Angioedema Attacks in the Phase 3 KONFIDENT Trial
Long-Term Prophylaxis Compliance for Hereditary Angioedema and the Impact on On-demand Treatment Claims
Survey Results from Italy, the US, UK, and France: Anxiety in Patients Using Injectable On-Demand Treatments for Hereditary Angioedema Attacks